MeiraGTx Holdings plc Inventory, Work in Process, Gross
MeiraGTx Holdings plc (MGTX) had Inventory, Work in Process, Gross of $732.00 thousand as of 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Balance Sheet › Assets › Assets, Current
us-gaap:InventoryWorkInProcess · last filed 2024-03-15
- 2023-09-30: Inventory, Work in Process, Gross $732.00K.
- 2022-12-31: Inventory, Work in Process, Gross $742.00K.
| Period end | Inventory, Work in Process, Gross |
|---|---|
| 2023-09-30 | $732.00K 10-Q · filed 2023-11-14 |
| 2022-12-31 | $742.00K 10-K · filed 2024-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Replimune Group, Inc. (REPL) | United States | $1.186B | -3.13 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |